Neurogenesis is known to take a series of cellular programming events from initial morphogenesis to subsequent maturation to form distinct cell subtypes in the nervous system 1,2 . These sequential events are likely induced by specific morphogenetic signals in combination with step-wise activation or repression of cell-autonomous gene expression programs, as indicated by expression waves of lineage-specific transcription factors 3 and their distinct functional requirements 4 . While most of our knowledge about neurogenesis in mammals is derived from genetically tractable systems, particularly mice, we know relatively little about the parallel process in humans. Mice and humans are clearly different in brain size and the time required for neural development, which may thus involve distinct regulatory strategies 5 , and understanding such critical differences is vital for using mice as models to study neural development and neurodegenerative diseases in humans 6, 7 .
a r t I C l e S
Neurogenesis is known to take a series of cellular programming events from initial morphogenesis to subsequent maturation to form distinct cell subtypes in the nervous system 1,2 . These sequential events are likely induced by specific morphogenetic signals in combination with step-wise activation or repression of cell-autonomous gene expression programs, as indicated by expression waves of lineage-specific transcription factors 3 and their distinct functional requirements 4 . While most of our knowledge about neurogenesis in mammals is derived from genetically tractable systems, particularly mice, we know relatively little about the parallel process in humans. Mice and humans are clearly different in brain size and the time required for neural development, which may thus involve distinct regulatory strategies 5 , and understanding such critical differences is vital for using mice as models to study neural development and neurodegenerative diseases in humans 6, 7 .
Recent breakthroughs in regenerative medicine provide new approaches to studying specific human diseases by using patientderived cells. Through reprogramming [8] [9] [10] , for example, human fibroblasts can be converted to induced pluripotent stem cells, which can be redifferentiated to specific cell types, such as neurons, for functional studies 11, 12 . Alternatively, fibroblasts can be directly transdifferentiated into neurons with a set of neuron-specific transcription factors [13] [14] [15] [16] [17] . Many studies have demonstrated the feasibility of such transdifferentiation approaches in mouse and human embryonic fibroblasts, but it is a general consensus that human cells are much harder to convert, especially those from aged patients 18 . This represents a significant barrier to directly using patient-derived fibroblasts to investigate disease mechanisms.
Most cell differentiation or transdifferentiation protocols developed were inspired by the success in induced pluripotent stem cells, which is to transduce a set of transcription factors specifically expressed in destination cells to a beginning cell type 19 . Such procedure is, however, a largely try-and-error process, although some recent efforts have been made toward a strategic approach by deducing critical developmentally regulated gene networks 20, 21 . In principle, any cellular reprogramming would require breakup of the existing homeostatic program followed by establishment of a self-sustaining new program, which likely involves sequential switches in various feedback controls. Notably, some specific small molecular inhibitors are able to replace transcription factors in inducing cellular reprogramming 22, 23 . However, little is known about the mechanisms underlying most induced pluripotency or transdifferentiation procedures.
Coordinated changes in the expression of regulatory RNAs and RNA binding proteins accompany switches in the expression of lineage-specific transcription factors, suggesting key functions in cellular reprogramming 24, 25 . Indeed, specific microRNAs, such as miR-124, have been shown to contribute to fibroblast conversion to neurons when coupled with certain transcription factors 26, 27 . We previously established the existence of a regulatory loop in which the transcription repressor REST represses miR-124, which in turn dismantles multiple components of the REST complex, and the RNA binding protein PTB (which is encoded by PTBP1; for simplicity, we use PTB as a gene alias) serves both as a substrate for and a key inhibitor of miR-124 targeting. We demonstrated that PTB knockdown is necessary and sufficient to potently activate this loop and turn mouse fibroblasts into functional neurons 28 .
Surprisingly, when applying the same protocol to humans, we were able to efficiently convert human fibroblasts to neuron-like cells with complex morphology, especially when combined with a set of small a r t I C l e S molecule inhibitors, but all induced neurons were immature, indicating that PTB knockdown is sufficient to activate a full neuronal program in mouse, but not human, cells. We now uncover a second loop that promotes neuronal maturation in human cells. It consists of the PTB paralog nPTB (which is encoded by PTBP2; we use nPTB as a gene alias); another neuron-specific miRNA, miR-9; and the transcription activator BRN2 (which is encoded by POU3F2; we use BRN2 as a gene alias). In this loop, BRN2 transcriptionally activates miR-9, which in turn post-transcriptionally diminishes nPTB. These findings highlight the intertwined regulatory loops that are sequentially required for cell fate switch to the neuronal lineage.
RESULTS

Initial barrier to neuronal conversion in human cells
The PTB-miR-124-REST loop is self-sustaining once triggered by initial PTB knockdown. Because the loop is conserved in mammals, we applied the same strategy to two primary HAF lines, derived from a 42-year-old male and an 86-year-old female. Both lines showed the expression of fibroblast markers, such as fibronectin, FSP1 and vimentin, without detectable contamination by neural cells, as indicated by the lack of a series of markers for neurons, neural crest progenitors or neural crest derivatives ( Supplementary  Fig. 1a) . PTB knockdown potently withdrew these cells from cycling, as shown by markedly reduced 5-ethynyl-2′-deoxyuridine (EdU) signals and increased cells in G2 ( Fig. 1a and Supplementary  Fig. 1b) , with 9-15% of the seeding cells showing bipolar neuronal morphology and positive staining for the pan-neuronal marker Tuj1 (Fig. 1b) . This conversion rate is similar to that in mouse embryonic fibroblasts (MEFs) 28 .
To increase the conversion efficiency, we tested a set of small molecules that have been reported to enhance neuronal differentiation [29] [30] [31] [32] [33] . None of these compounds alone was able to turn HAFs into Tuj1-positive cells (Supplementary Fig. 1c ), but when individual compounds were combined with PTB knockdown, we detected various levels of enhancement (Fig. 1c) . Initially, the induced neuron-like cells did not look healthy (Supplementary Fig. 1d ). We therefore titrated individual compounds and tested various combinations (Fig. 1c) , eventually establishing a three-small-molecule (3SM) combination (Fig. 1c) optimal for converting HAFs to Tuj1-positve cells in long-term culture. a r t I C l e S We monitored the conversion kinetics, and after conditioning the cells by PTB knockdown for 3 d, the 3SM cocktail was able to boost the number of Tuj1-positive cells as early as 3 h, reaching a plateau in ~1 d, while the fibroblast marker fibronectin gradually declined to nearly undetectable over a period of ~4 d, resulting in highly efficient conversion (~90%) of initial HAFs to Tuj1-positive cells (Fig. 1d,e) . In control shRNA-treated cells, while 3SM treatment for 3 h had no effect (Supplementary Fig. 1e ), continuous treatment with 3SM alone induced some transient effects on cellular restructuring, as indicated by vaulted nuclei (Supplementary Fig. 1e ). In contrast, PTB shRNA (shPTB) rapidly induced a persistent switch to neuronal morphology, 3SM treatment for 3 h enhanced the morphogenetic induction, and the continuous presence of 3SM yielded even stronger enhancement (Supplementary Fig. 1e ). These data established that the 3SM cocktail alone was insufficient, but its combination with shPTB potently induced a cell fate switch. The dramatic reduction in cycling cells coupled with negative staining for Nestin and Sox2 (both neural progenitor markers) strongly argue against the possibility of neural stem cell-like intermediates during this conversion process ( Fig. 1a and Supplementary Fig. 1f ). Of note, if we applied the same protocol optimized for HAFs to MEFs, cells died rapidly (data not shown), indicating critical differences in kinetic requirement between mouse and human cells.
A second human-specific barrier to neuronal maturation To our surprise, we detected little expression of markers for mature neurons, such as MAP2, neurofilament (NF) and NeuN, in shPTB/ 3SM-treated cells, indicating that the converted neuron-like cells from HAFs were arrested at an immature stage ( Fig. 2a and Supplementary  Fig. 2a ). As expected, we failed to record any neuronal activity-for example, Ca 2+ influx in response to membrane depolarization or the induction of action potentials upon current injection-even on a r t I C l e S prolonged culture of the converted cells. This indicates a second barrier to neuronal maturation: maturation appears to be automatically invoked in MEFs, as we showed previously 28 , but not in HAFs.
To search for the missing regulator(s), we performed RNA-seq on converted neuron-like cells in comparison with beginning HAFs. We noted the induction of a large panel of REST target genes. However, unlike in MEFs, we observed a sustained increase in mRNA for the RNA binding protein nPTB, a PTB paralog in the nervous system, in PTB-depleted HAFs (Supplementary Fig. 2b ). As nPTB is known to be induced for several days during initial neuronal induction, followed by graduate decline when neuroblasts are differentiated into functional neurons 34, 35 or during cortical development 36 , we hypothesized that dynamic regulation of nPTB might be a key difference between murine and human cells during transdifferentiation. To test this hypothesis, we monitored nPTB expression after PTB knockdown in both MEFs and HAFs. In contrast to MEFs and consistent with the RNA-seq data, we found that the induced nPTB protein showed persistent expression in neuron-like cells from HAFs (Fig. 2b,c) . This suggests a human-specific barrier to neuronal maturation.
Overcoming both barriers by sequential PTB/nPTB knockdown To test the two-barrier hypothesis, we generated an inducible knockdown cell line by infecting HAFs with four validated lentiviral shRNA pools against nPTB (Supplementary Fig. 2c,d) . Curiously, we observed cell death if PTB and nPTB were co-depleted in both MEFs and HAFs (data not shown), indicating that a sequential process is critical for neuronal differentiation despite the likely timing difference between mouse and human cells. We therefore tested PTB knockdown with shRNA, followed by selection with hygromycin for 3 d and then depletion of nPTB (indicated by RFP expression from the shnPTB expression unit) upon doxycycline addition at different time points (Fig. 2d) . After seeding PTB knockdown cells in differentiation medium for 2 d or beyond, nPTB knockdown generated healthy, MAP2-positive (stained at day 14) cells (Fig. 2e) . The resulting neuron-like cells remained healthy in culture for 3 months, the longest time we tested.
We next determined whether such neuron-like cells produced by sequential PTB and nPTB knockdowns possessed neuron-specific membrane properties. We detected fast-activating and inactivating inward Na + currents and outward K + currents after doxycycline treatment for 4 weeks followed by co-culturing with GFP-marked glial cells for another 2 weeks (Fig. 2f) . The Na + currents could be blocked by the voltage-gated sodium channel-specific inhibitor tetrodotoxin (TTX), which could be partially relieved after washing out the inhibitor, indicative of an active binding and passive disassociation process (Fig. 2f) . We also observed repeated action potentials upon current injection (Fig. 2g) . The cells also expressed functional GABA A -receptors, a r t I C l e S as based on their response to GABA, which could be specifically blocked by picrotoxin (PiTX), a GABA A receptor-specific inhibitor (Fig. 2h) . We also detected spontaneous postsynaptic currents of various amplitude and frequencies, which could be sequentially blocked by inhibitors against the excitatory (NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione) + APV (dl-2-amino-5-phosphonovaleric acid)) and inhibitory (NBQX + APV + PiTX) receptors (Fig. 2i-k) . Collectively, these data demonstrate the functionality of induced neurons from HAFs by sequential PTB and nPTB knockdown in the presence of glial cells.
nPTB regulates BRN2 during neuronal maturation The above data suggest that nPTB knockdown is sufficient to overcome a critical barrier to neuronal maturation, indicating the activation of a new regulatory program. To understand the mechanism, we examined the expression of key transcription factors previously shown to generate functional neurons in human cells 14 . This revealed their induction, with one exception, by PTB knockdown (Fig. 3a) , consistent with these genes being targets for REST in HAFs ( Supplementary  Fig. 3a) . The exception was BRN2, a cortex-specific transcription factor 37 , which remained repressed in PTB knockdown HAFs (Fig. 3a) . Notably, sequential knockdown of PTB and nPTB potently induced BRN2 expression (Fig. 3b) .
We next determined the potential contribution of activated BRN2 to neuronal maturation. We first tested various combinations of transcription factors in combined with PTB knockdown, finding that the inclusion of BRN2 was critical for efficient MAP2 expression (Supplementary Fig. 3b ) and for invoking Ca 2+ influx . t = 9.356, P = 0.000727; box 7 versus 8: υ = 9, t = 3.066, P = 0.0134; box 7 versus 9: υ = 9, t = 8.037; P = 0.0000213. (g) BRN2 ChIP-qPCR analysis (with C-20 antibody; IgG as negative control) on MIR124 and MIR9 loci in HAF-derived neurons after sequential knockdown of PTB and nPTB. For box 1 versus 2: υ = 3, t = 6.484, P = 0.0074; box 3 versus 4: υ = 4, t = 16.616, P = 0.00076; box 2 versus 4: υ = 3, t = 5.446, P = 0.0122; box 5 versus 6: υ = 4, t = 12.795, P = 0.00022; box 4 versus 6: υ = 4, t = 5.154, P = 0.0067; box 7 versus 8: υ = 3, t = 13.218, P = 0.00094; box 9 versus 10: υ = 4, t = 30.228, P = 0.000007; box 11 versus 12: υ = 4, t = 5.684, P = 0.0047. n = 3 independent experiments. (h) RT-qPCR analysis of miR-124 and miR-9 after PTB knockdown or sequential PTB and nPTB knockdown in HAFs. U6 served as internal control. For miR-9: box 1 versus 2: υ = 4, t = 3.496, P = 0.0249; box 1 versus 3: υ = 4, t = 17.595, P = 0.0000613; box 2 versus 3: υ = 4, t = 8.835, P = 0.00091. For miR-124: box 1 versus 2: υ = 3, t = 11.886, P = 0.00128; box 1 versus 3: υ = 4, t = 11.572, P = 0.00032; box 2 versus 3: υ = 3, t = 9.315, P = 0.00262. n = 3 independent experiments. ns, non-significant; *P < 0.05, **P < 0.01, ***P < 0.001. All data are mean ± s.d. In box plots, center line is the median, box limits are the lower quartile (Q1) and upper quartile (Q3), and whiskers are the most extreme data points that are no more than 1.5 × (Q3 -Q1) from the box limits. See also Supplementary Figure 4 and the list of primers in Supplementary Table 3 . npg a r t I C l e S (Supplementary Fig. 3c) . We then engineered an inducible polycistronic unit in a stable HAF line to express both shPTB and BRN2 (Fig. 3c) . Doxycycline treatment induced rapid PTBP1 knockdown and gradual BRN2 expression, and after 2 weeks of such treatment, we detected multiple markers for mature neurons, including MAP2, NCAM, vGLUT1 and NeuN (Fig. 3c) .
To demonstrate the functionality of these neurons, after 1 week of culture with GFP-marked glial cells, we recorded TTX-sensitive sodium currents (Fig. 3d) , current-triggered repeated action potentials (Fig. 3e) , occasional spontaneous action potentials (Fig. 3f) , and functional AMPA and NMDA currents characterized by using specific inhibitors (Fig. 3g) . After culturing with GFP-marked glial cells for 3 to 4 weeks (Fig. 3h) , we detected spontaneous postsynaptic activities of variable amplitudes and frequencies (Fig. 3i-k) . Neurons induced by sequential knockdown of PTB and nPTB or by PTB knockdown coupled with BRN2 overexpression were similar as based on several key electrophysiological properties (Supplementary Table 1) .
Collectively, these data demonstrate that PTB knockdown plus BRN2 expression is sufficient to produce functional neurons from HAFs.
BRN2 is essential for hNPC differentiation
We next wished to establish functions of BRN2 in neuronal maturation in a different physiological context: namely, differentiation of human neural progenitor cells (hNPCs) to cortical neurons upon withdrawal of basic fibroblast growth factor from culture medium 38 . These hNPCs showed positive expression of neural stem cell-specific markers, such as nestin, Sox2, and BRN2 (Supplementary Fig. 4a) . Upon BRN2 knockdown, we found that, while early neuronal differentiation events were not affected, as evidenced by normal Tuj1 expression (Fig. 4a) , the expression of MAP2, a marker associated with more mature neurons, was severely compromised (Fig. 4b and  Supplementary Fig. 4b,c) . BRN2 is similarly required for the expression of the mature neuron marker NeuN in PTB/nPTB sequential knockdown cells (Supplementary Fig. 4d ). Inward Na + currents (Fig. 4c) were rarely detected in BRN2-depleted hNPCs (Supplementary Fig. 4e ). These data demonstrate that BRN2 is required for hNPC differentiation into functional neurons.
BRN2 activates neuron-specific miRNAs
To understand how BRN2 mediates neuronal maturation, we further took advantage of the hNPC system to perform BRN2 chromatin immunoprecipitation and sequencing (ChIP-seq) with two independent antibodies (C-20 and B-2) before and after hNPC differentiation ( Supplementary Fig. 4f,g ). We detected ~5,000 BRN2 binding peaks in 3,987 genes (Supplementary Table 2 (h) MAP2 and NeuN expression in HAF-derived neurons upon PTB knockdown or sequential PTBP1 and nPTB knockdown plus the ectopic expression of an shRNAresistant Flag-tagged nPTB (n = 2 independent experiments). CDSM, coding sequence mutation All data are mean ± s.d. Two-tailed unpaired Student's t test (*P < 0.05, **P < 0.01, ***P < 0.001). In box plots, center line is the median, box limits are the lower quartile (Q1) and upper quartile (Q3), and whiskers are the most extreme data points that are no more than 1.5 × (Q3 -Q1) from the box limits. Uncropped versions of western blots are shown in Supplementary Figure 7 .
a r t I C l e S regulates a large repertoire of genes critical for neurogenesis and maturation ( Supplementary Fig. 4h,i) . Among BRN2 targets, we noted that BRN2 directly bound the MIR124-3 gene on chromosome 20 and the MIR9-2 gene on chromosome 5 (Fig. 4d) . In contrast to the MIR124-3 locus, which showed unaltered BRN2 binding before and after hNPC differentiation, BRN2 on multiple locations in the MIR9-2 locus became detectable only in differentiated hNPCs (Fig. 4d) , which we further validated by ChIP followed by quantitative PCR (qPCR) (Fig. 4e) . By monitoring mature miR-124 and miR-9 with miR-21 as a negative control in shPTB-treated HAFs, we again detected the induction of miR-9, but not miR-124, in response to BRN2 overexpression for 6 d, although both miRNAs were induced after prolonged BRN2 expression for 12 d (Fig. 4f) . These data suggest that BRN2 binds and regulates MIR124 expression in hNPCs, but such modest levels of miR-124 in hNPCs appears insufficient to trigger neuronal differentiation. In contrast, BRN2-regulated miR-9 seems to drive neuronal differentiation, consistent with the burst induction of the miR-9-2 precursor between E12.5 and E13.5, when BRN2 begins to express in the mouse brain [39] [40] [41] .
We also confirmed BRN2 binding to both MIR9 and MIR124 loci in HAFs treated with shPTB and shnPTB (Fig. 4g) . MIR9 showed progressive induction in response to sequential knockdown of PTB and nPTB in HAFs (Fig. 4h) . In contrast, MIR124 was highly induced in response to PTB knockdown, but, for unknown reasons, it became repressed in HAFs treated with shPTB and shnPTB (Fig. 4h) . In any case, these data suggest that MIR124 induction may responsible for neuronal conversion and subsequent MIR9 activation may account for progression of induced neuron-like cells to functional neurons.
The nPTB-BRN2-miR-9 loop for neuronal maturation The induction of miR-9 by BRN2 provides a clue to a new regulatory axis for neuronal maturation, as we noted potential target sites for both miR-9 and miR-124 in the 3′ UTR of nPTB with typical base-pairing potentials in prospective seed regions (Fig. 5a) . We thus asked whether these two neuron-specific miRNAs were able to diminish the expression of endogenous nPTB. A previously study showed that miR-124 potently inhibits PTB with relatively minor effects on nPTB 42 . In PTB-downregulated HAFs, we found that both miR-124 and miR-9 mimicked downregulation of nPTB at both mRNA and protein levels (Fig. 5b,c) . As expected, shBRN2 prevented nPTB downregulation while BRN2 overexpression diminished nPTB induction in shPTB-treated HAFs (Supplementary Fig. 5a,b) . To further test these miRNAs in post-transcriptional regulation of nPTB, we expressed specific sponges for these miRNAs in hNPCs, finding significantly increased nPTB expression (Fig. 5d,e) . The sponges similarly prevented nPTB downregulation and diminished NeuN expression in HAF-derived neurons (Fig. 5f) , consistent with early works that established that both miRNAs are essential in maintaining neuron viability of differentiated hNPCs 43, 44 .
We next verified the deduced targeting sites in the 3′ UTR of nPTB. We constructed a luciferase reporter containing the nPTB 3′ UTR and tested the effects of transfected miRNA mimics, with a universal siRNA as a negative control. We found that both miR-124 and miR-9 mimics repressed the reporter activity, and specific mutations in the predicted target sites diminished the miRNA-induced downregulation of the reporter (Fig. 5g) . Of the two potential miR-124 target sites in the nPTB 3′ UTR, the first seemed to be the primary functional site because mutation of that site largely prevented miR-124-mediated downregulation (Fig. 5g) .
We emphasize that, although forced miR-124 overexpression or miR-124 depletion by sponge were able to affect nPTB expression, it is the BRN2-miR-9-nPTB axis that seems to be critical for neuronal maturation under physiological conditions, as immature neurons induced by shPTB alone expressed high levels of miR-124. To further demonstrate that diminished nPTB expression is key to neuronal maturation, we expressed a shRNA-resistant form of nPTB in neurons induced from HAFs by shPTB and shnPTB. This reduced MAP2 to basal levels and, more importantly, completely prevented the induced expression of NeuN (Fig. 5h) .
Considered together, the data presented in Figures 3-5 suggest a previously unrecognized loop for driving neuronal maturation in PTB-depleted HAFs (Supplementary Fig. 6 ). In this loop, nPTB downregulation directly or indirectly triggers the activation of BRN2; activated BRN2 binds and transcriptionally induces MIR9; and, finally, elevated miR-9 post-transcriptionally diminishes nPTB. Therefore, like the PTB-REST-miR-124 loop for neuronal conversion, this nPTB-BRN2-miR-9 loop, once triggered, becomes selfsustaining for neuronal maturation.
DISCUSSION
Physiological relevance of the sequential regulatory loops Neuronal differentiation is a tightly controlled process, as indicated by the sequential expression of transcriptional and post-transcriptional regulators. The two separate yet highly intertwined loops we have elucidated are consistent with the neurogenesis program in vivo. PTB is well known to maintain neural stem cell pools, as its ablation causes precocious neural differentiation and massive depletion of neural stem cells in the mouse 45 . The effect of PTB knockout is largely phenocopied by REST knockout, suggesting that they function in a common pathway during neuronal induction 46 . As both PTB and REST are constitutively expressed in non-neuronal cells, it is likely that their inactivation in developing neurons is triggered by induced MIR124 expression 42 . Our previous work 28 revealed a double-negative feedback loop consisting of PTB, miR-124, and REST (Supplementary Fig. 6 ). Once triggered, the loop becomes self-sustaining and dismantled REST is responsible for de-repressing a large number of neuron-specific genes to drive neurogenesis 28 . It is important to note here that REST dismantling induced by miR-124 is fundamentally distinct from REST knockout, as residual levels of REST appear to be required for ensuring the healthy state of differentiated neurons 46 .
A key functional consequence of PTB inactivation is de-repression of nPTB due to the inclusion of a PTB-suppressed exon 34, 42, 47 , a process that occurs in the early phase of neural development 35 . Our new data show that nPTB is also negatively regulated by miR-124, which may counteract PTB knockdown-induced nPTB expression, thereby maintaining relatively stable nPTB expression during the transition from immature to mature neurons. The transient nPTB expression is coincident with the induction of both BRN2 and MIR-9 around E13.5; however, it has been unclear how nPTB is switched off during neuronal maturation 39, 40 . We now establish that these three components form a feedforward loop (Supplementary Fig. 6 ) and the full activation of this loop underlies gradual nPTB switch-off in more mature neurons 36, 48 . It remains to be defined which developmental cue(s) triggers this loop in human brain.
Key difference between mouse and human neurogenic programs Mouse has been a prominent model for studying neurogenesis and neurodegeneration in humans. However, mouse and human are npg evolutionarily different in many ways. One of the fundamental differences is neocortex expansion, which is mainly due to increased amplification of neural progenitor cells during embryonic corticogenesis 49 . The tightly controlled neuronal conversion and maturation loops might serve as gatekeepers to ensure programmatic switches in a sequential manner during brain development, as simultaneous knockout of PTB and nPTB produced a lethal phenotype, even in cell lines. Notably, while the optimal neuronal conversion protocol developed for mouse cells is insufficient to produce functional neurons from human cells, the optimized protocol developed in human cells caused a lethal phenotype in mouse cells, suggesting that cells from different mammals may have their own built-in timing mechanisms.
Such separate timing mechanisms between mouse and human cells are underscored by the observation that the PTB-and nPTB-mediated loops seem to be automatically connected in murine cells but need to be separately activated in human cells. While we are still early in understanding such species-specific mechanisms, one potential mechanism might be due to distinct regulatory programs for inducing miR-124 and miR-9 between mice and humans. miR-124 is known to be gradually induced during neurogenesis, while the induction of miR-9 expression is largely coincident with neuronal maturation 25 . It is therefore conceivable that the initial induction of miR-124 might be responsible for downregulating both PTB and nPTB in mouse cells, but predominantly PTB in human cells. It is likely that miR-124 is more efficient in targeting PTB than nPTB even in mouse cells, as simultaneous inactivation of both PTB and nPTB would severely compromise the viability of differentiating neurons.
Regulation of BRN2 expression is an obvious contributor to neuronal maturation, but other neuron-specific transcription factors, such as NeuroD1, may be also involved 14 . One of those matureneuron-specific transcription factors may be responsible for further elevation of miR-124, joining force with BRN2-induced miR-9 in later phases of neurogenesis. Therefore, various combinations of empirically tested transcription factors might all be able to partially activate both neuronal conversion and maturation programs but unable to fully activate these programs in all transfected cells. As neuronal reprogramming of human cells appears to be stringently controlled by some critical gatekeepers, including the two elucidated in the present study, such opportunistic activation of the neural program may thus account for the overall low conversion efficiency in human cells.
Mechanisms underlying PTB-and nPTB-regulated gene expression PTB and nPTB are well-known splicing regulators 34, 36, 42, 47, 48, 50 . Despite their similar biochemical properties in RNA binding and biological functions in regulated splicing, they clearly have nonredundant functions in development, as based on knockout study results in mice 36, 45, 48 . Our recent study reveals that, besides its traditional role as a splicing regulator, PTB also binds numerous sites in the 3′ UTRs of many genes to either compete for miRNA targeting or alter RNA secondary structure to promote miRNA targeting, thus modulating miRNA functions in both directions 28 . Our earlier work 28 demonstrated that this new function of PTB is largely responsible for miR-124-mediated dismantling of the REST complex during neuronal conversion.
Here we have uncovered a critical role of regulated nPTB expression in neuronal maturation. Previous studies have elucidated the function of nPTB in the regulation of neuron-specific alternative splicing events, which undoubtedly contribute to various phenotypes associated with mature neurons 34, 36, 48 . We now demonstrate a key role of nPTB downregulation in driving neuronal maturation via the activation of the nPTB-BRN2-miR-9 loop. In this loop, BRN2 likely activates transcription from MIR9 and induced miR-9 in turn inactivates nPTB via its targeting site in the 3′ UTR, but it is unclear how downregulation of nPTB leads to BRN2 activation. Future studies will thus address how nPTB downregulation may activate BRN2, either directly via a transcriptional de-repression mechanism or indirectly through induced splicing events of other genes in mature neurons. The established cellular model will empower this and other mechanistic studies in a biologically relevant context.
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